Country Chair, Sanofi Kazakhstan
General Manager RX, Sanofi Central Asia
Vitaly is Country Chair, Sanofi Kazakhstan and General Manager RX, Sanofi Central Asia since August 2019. He has more than 18 years of managerial experience in pharmaceutical industry, where he has held various positions in global pharmaceutical companies. Prior to joining the Sanofi Central Asia Team, Vitaly was the Sanofi Diabetes Business Unit Head in Russia.
Since 2013, Vitaly has implemented several successful transformational projects at Sanofi, has modified a business model and structure of the business unit, and made a significant contribution into the development of a culture of affiliate. As a Head of Diabetes franchise, Vitaly successfully launched one of key innovative products. This launch got the International Award as the Sanofi best launch in the world.
Vitaly is a graduate of Chelyabinsk State Medical Academy as Anesthesiologist-Resuscitator, and has an MBA Degree from the Moscow International Higher Business School (MIRBIS).
Vitaliy has been working as a Country Manager in AbbVie Biopharmaceuticals GmbH for 5 years. He also worked for such companies as Abbott Ukraine Ltd., Janssen-Cilag, KRKA.
Vitaliy has a successful experience in managing sales and marketing teams in international pharmaceutical companies. He has a wide business connection in the field of pharmaceutical market (Ukraine and Moldova). Competent in marketing, sales, conducting negotiations and managing different organizations, teams and projects.
Vitaliy is a member of the following organisations:
APRaD (Association of Pharmaceutical Research and development): BoD
Chairman of the Board
ACC (American Chamber of Commerce) Co-chair of HC committee since 2013
USUBC (US-Ukraine business council) BoD member since 2008
Roger Elia is the General Manager of Merck Biopharma in CIS
Born in 1976 in Lebanon. Roger holds MBA in Finance & Marketing. Roger lived and worked in Lebanon, Russia, CIS and South Korea. Since 2018 he has been living and working in Russia.
2018 – now
General Manager of Merck Biopharma in CIS
Business Unit Head at Merck Ltd Korea
2014 – 2015
Strategic Alliance Leader at Merck LLC Russia
2011 – 2014
Marketing Manager at Merck LLC Russia
Market Access and Pricing Head at Novartis Oncology Russia
Various management positions at Pharmonyx Ltd in Russia and CIS
1994 – 2003
Medical Academy, Moscow
Mariya graduated from Medical University and Clinical Residency with a specialization in Cardiology and received the education in Strategic Management at business schools in Lausanne (Switzerland) and Singapore.
Mariya began her career in the pharmaceutical business as a medical representative, then gained experience in marketing and in 2009 became the head of the Nephrology Business Unit of Amgen. Having formed a strong sales & marketing team, Maria was able to bring the company's nephrology business to a qualitatively new level, demonstrating the highest results of work in the company for two years in a row.
In 2014, Maria accepted an offer to head a completely new direction for the company, standing at the origins of the formation of the Market Access function in the Russian pharmaceutical market and the CIS markets.
In 2018, in the role of Global Value Access & policy director for Russia and CEE countries, she moved to Alexion, where, under her leadership the company's leading drugs were included in the state drug lists. In 2019, Maria joined Ipsen as Market Access and Public Affairs Director, Russia & CIS, taking a course to strengthen the company's reputation as a reliable partner of the state and society, offering innovative solutions for patients in various therapeutic areas.
+ 10 years of working experience in public
administration in customer Service, and
at Merck in the supply chain management
of medicinal products
Since February 2018: Supply Chain Head, Merck Biopharma Russia & CIS
2015 ~ 18 Demand Planning Manager; Merck Spain
2012 ~ 15 Customer Service Technician, Customer Service Manager; Open Administration Consortium
2006 ~ 12 Product Manager, Project Manager; Catalan Certification Agency
Marina Durmanova is the President of the Republic of Kazakhstan Pharmaceutical Activity Support and Development Association the participants of which are the national and foreign pharmaceuticals manufacturers, distribution companies and pharmacy organizations. Represented by Marina Durmanova, the Association takes an active part in standard setting process. She is a member of the task groups under the Mazhilis (the lower house) of the Parliament that discuss various draft laws in the public health sphere.
The Association s a member of the Social Council under the Republic of Kazakhstan Public Health Ministry, National Scientific Council operating in the sphere of the life science and health with pharmaceutical science as the priority line, Republic of Kazakhstan Public Health Ministry’s collegium, formulary commission under the RK Public Health Ministry, Expert and Business Council under the Almaty Akimat (City Executive Board). She has been accredited by the Republic of Kazakhstan National Chamber of Entrepreneurs and is a member of the Pharmaceutical and Medical Industry Committee under the RK NCE Atameken.
The Republic of Kazakhstan Pharmaceutical Activity Support and Development Association is a member of the task group in charge of development of general approach to control of pharmaceuticals and medical products circulation within the boundaries of the Customs Union and the Common Economic Area.
Marina Durmanova has repeatedly received state awards for her contribution to development of the national public health sphere.
Ebru Yavuz is a Chemical Engineer with an MBA degree with more than 20 years of professional experience in the pharmaceutical industry with solid experience in regulatory affairs, pricing, reimbursement, government affairs, public affairs, corporate communications and in strategic management.
Ebru joined Takeda in February 2016. In her previous position as Head of Business Operations at Takeda Pharmaceuticals for ICMEA (India, CIS without Russia, the Middle East, Turkey, and Africa), Ebru was responsible for internal and external communications, developing strategies, managing strategic projects, leading sales force effectiveness, improving business processes, and optimizing the company's operations in the region.
As General Manager in Ukraine and CIS Cluster, Ebru Yavuz focuses on meeting the needs of patients in innovative therapies, the sustainable growth of business in the cluster countries, especially Ukraine.
Before she joined Takeda in 2016; she worked for 13 years at Novo Nordisk and 5 years in Bilim Pharmaceuticals in Turkey.
Dr. Aleksandr Solodovnikov has 14 years of clinical trial expertise as an investigator, CRA, clinical operations trial lead and clinical operations manager in fields of Endocrinology, Psychiatry, Cardiology, Pulmonology, Oncology, Hematology, Dermatology, Neurology, Surgery and Infectious Diseases (more than 30 trials, phase I-IV).
Aleksandr graduated from the Ural State Medical Academy (now University) in 2003 and started his scientific career at the Chair of preventative and family medicine resulting in a PhD in Rheumatology in 2009. Dr. Solodovnikov is now an associate professor of this Chair supervising edivence-based medicine and biostatistics fields. Aleksandr received his training in statistics and epidemiology at the University of Manchester, UK, and at the Erasmus University, the Netherlands, and personally prepared and conducted more than 300 various statistical analyses in various statistical software packages (NCSS, Stata, R, SPSS, Statistica and other) and provided a lot of consultations in this field. He further developed his professional skills in clinical research by taking the “Principles and Practice of Clinical Research” course at Harvard Medical School in 2014. In 2016, Aleksandr also successfully completed the “Project Management Professional”.
Dr. Solodovnikov is a skillful trainer and lecturer, and has conducted numerous GCP trainings as well as seminars in biostatistics, evidence-based medicine, clinical research, drug development and regulations in clinical trials. He knows local, regional (EAEU) and international clinical trial regulations and guidelines well, and took part in the development of hundreds of clinical trial documents for medicines, medical devices, cosmetic and dietary products, and biologically active substances, starting from study concept and ending with the final protocol.
Vaghinak Grigoryan was born in 1989 in Yerevan, Armenia. Holds a Master's Degree in Pharmacy. GMP/GDP coordinator and auditor.
2020 - now Quality Director at "Esco Pharm" Ltd. (Yerevan, Armenia)
2018 - now Quality Manager at "Esculap" Ltd (Yerevan, Armenia)
2015-2020 - Head of Quality Assurance at "Esco Pharm" Ltd (Yerevan, Armenia)
2014-2015 - Sales manager at "OTC Pharma" (Vladivostok,Russia)
2012-2014 - Senior Pharmacist at "Lotus" Medical Centre (Abu Dhabi, UAE)
Alexey brings 10 years of consulting experience across a variety of sectors with focus on healthcare and pharmaceutical industry in Russia, Ukraine, Kazakhstan and globally in Europe
Alexey has been a part of 100+ projects on strategic, commercial, marketing and manufacturing issues with multinational and local clients in healthcare
Before joining IQVIA he worked for KPMG Strategy leading strategic and operational projects
MBA from IE Business School (Madrid), MA and BA from Higher School of Economics (Moscow)
Evgeniy Kunda built a successful career in Proxima Research LLC, starting with the position of the analyst to the Commercial director of Proxima Research International.
Over 15 years he has been involved in the management and participates in the project`s development.
His achievement is the expansion of the information space in the CIS countries.
Now, the main task of Evgeniy is to optimize existing services and business processes, build effective communication with global IT vendors and Proxima`s business partners, formation of a development strategy, search for and launch innovative SFE-solutions for the Pharma market.
Head of Government Relations Department, GEROPHARM
Vilena graduated from the State University of Management with a degree in Public Relations in 2008. In 2018, she completed additional education at the St. Petersburg State Chemical and Pharmaceutical University, Department for Regulation of Circulation of Medicines in Pharmaceutical Market.
Her professional experience in pharmaceutical business goes back to 2008. She worked in consulting companies cooperating with major international and Russian companies.
In 2012, she joined GEROPHARM. Vilena is an expert and a regular participant in discussions on topical issues related to industry regulation.